Cases and resources in vascular techniques

At Charing Cross 2026, Dr Lichtenberg presented long-term data on venous stenting for acute and chronic femoral DVT. In a cohort of 80 patients followed for up to 8 years, most loss of patency occurred within the first 6 to 8 months, with early re-occlusion—likely linked to inflow issues—identified as the main cause of failure.

During a short interview recorded for PVI online at Charing Cross 2026, Prof. Secemsky discusses ongoing developments in bioresorbable scaffold technology and the key elements surrounding next-generation devices in below-the-knee intervention.

In this PVI 2025 interview, Dr Hideaki Obara discusses why open surgery remains the preferred treatment for common femoral artery disease in Japan. He reviews data from a multicentre study showing low complication rates with common femoral endarterectomy and compares these findings with outcomes from endovascular approaches.

A 63-year-old man with multiple prior left carotid surgeries and a bovine aortic arch presented with a large carotid aneurysm. Open repair was high-risk, leaving the team to weigh complex anatomical and technical challenges. How should such a case be managed—and what was ultimately done?

In the SirPAD trial, sirolimus-coated balloon angioplasty significantly reduced major adverse limb events at 1 year compared with uncoated balloon angioplasty in patients undergoing endovascular treatment for infrainguinal artery disease, while maintaining a similar safety profile.

During a short interview recorded at Charing Cross 2026 exclusively for PVI online, Dr Stefano Barco reviews the rationale, design and key findings of the SirPAD trial, which evaluated whether a sirolimus-coated balloon could improve clinically relevant outcomes compared with an uncoated balloon in patients undergoing endovascular treatment for PAD.

Dr. Marc Schermerhorn discusses outcomes after failed EVAR, comparing secondary FEVAR with primary procedures. He highlights reasons for increased sac growth in post-EVAR cases and shares practical tips for managing challenging anatomy such as tortuosity and short main bodies.

How are new endovascular devices changing pulmonary embolism treatment? In this PVI 2025 interview, Dr. Varinder Singh Bedi discusses current approaches, procedural tips, and the realities of pulmonary embolism management in India.

A 56-year-old patient presents with acute limb ischemia and complex multilevel arterial disease, including common femoral artery occlusion. What would be the optimal revascularisation strategy in this setting?

This PVI 2025 interview explores drug-coated balloons in BTK disease, with insights from the RANGER trial. It reviews key outcomes, including wound healing and amputation-free survival, and safety considerations around paclitaxel, including prior evidence such as SWEDEPAD. Practical implications for CLTI patient management are also discussed.